Amid Uproar, Novartis Files Gleevec Appeal
Spurring widespread protests, Novartis AG on Monday filed an appeal in its ongoing battle to patent its cancer treatment Gleevec in India, asking the Madras High Court to clarify a key...To view the full article, register now.
Already a subscriber? Click here to view full article